1.14
전일 마감가:
$1.18
열려 있는:
$1.17
하루 거래량:
5.68M
Relative Volume:
2.90
시가총액:
$208.98M
수익:
$137.74M
순이익/손실:
$-27.97M
주가수익비율:
-7.125
EPS:
-0.16
순현금흐름:
$-9.61M
1주 성능:
-4.20%
1개월 성능:
-13.64%
6개월 성능:
-50.65%
1년 성능:
-35.96%
Heron Therapeutics Inc Stock (HRTX) Company Profile
명칭
Heron Therapeutics Inc
전화
(858) 251-4400
주소
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
HRTX
Heron Therapeutics Inc
|
1.14 | 216.31M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-09 | 개시 | H.C. Wainwright | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-23 | 개시 | CapitalOne | Overweight |
| 2024-03-13 | 재확인 | Needham | Buy |
| 2020-05-27 | 개시 | Guggenheim | Buy |
| 2020-02-20 | 재확인 | Needham | Buy |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-04-05 | 개시 | Evercore ISI | Outperform |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2018-03-01 | 재확인 | Needham | Buy |
| 2018-01-03 | 개시 | Leerink Partners | Outperform |
| 2017-09-27 | 개시 | Northland Capital | Outperform |
| 2017-02-27 | 개시 | Needham | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-09-06 | 재개 | Lake Street | Buy |
| 2016-05-03 | 개시 | Cantor Fitzgerald | Buy |
| 2015-12-10 | 개시 | Lake Street | Buy |
| 2015-09-23 | 재확인 | Leerink Partners | Outperform |
| 2015-09-02 | 개시 | BofA/Merrill | Buy |
| 2015-08-03 | 재확인 | Brean Capital | Buy |
| 2015-06-30 | 재확인 | JMP Securities | Mkt Outperform |
| 2015-06-19 | 재확인 | Leerink Partners | Outperform |
| 2014-08-07 | 개시 | Noble Financial | Buy |
모두보기
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com
Key facts: Heron Therapeutics reaffirms 2025 revenue guidance; Q3 loss widens - TradingView
Heron Therapeutics Posts Strong Q3 Growth And Upbeat Guidance - Finimize
Heron Therapeutics: Q3 Earnings Snapshot - Chron
Heron Therapeutics Q3 2025 slides: strong product growth despite earnings miss - Investing.com Canada
Heron Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Sentiment analysis tools applied to Heron Therapeutics Inc.2025 Price Momentum & Fast Momentum Entry Tips - newser.com
Heron Therapeutics Inc. Q3 Loss Increases, Misses Estimates - Nasdaq
Heron Therapeutics Q3 2025 Financial Results - TradingView
HERON THERAPEUTICS, INC. /DE/ SEC 10-Q Report - TradingView
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress - GlobeNewswire
Heron Therapeutics Inc. stock daily chart insightsJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
Ranking Heron Therapeutics Inc. among high performing stocks via toolsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
Will Heron Therapeutics Inc. stock benefit from automation2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could rally stronglyStop Loss & High Accuracy Swing Entry Alerts - newser.com
Can Heron Therapeutics Inc. stock weather global recessionShare Buyback & Safe Entry Point Alerts - newser.com
Detecting price anomalies in Heron Therapeutics Inc. with AIJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - newser.com
Heron Therapeutics Inc. stock chart pattern explainedEarnings Risk Summary & Reliable Price Breakout Signals - newser.com
Can Heron Therapeutics Inc. (AXD2) stock deliver consistent EPS growthMarket Performance Report & AI Powered Market Entry Strategies - newser.com
What analyst consensus says on Heron Therapeutics Inc. stockJuly 2025 Market Mood & Accurate Intraday Trade Tips - newser.com
Can trapped investors hope for a rebound in Heron Therapeutics Inc.2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Can Heron Therapeutics Inc. recover in the next quarterPrice Action & Precise Entry and Exit Recommendations - newser.com
Heron Therapeutics Inc. stock prediction for this week2025 Historical Comparison & Consistent Growth Stock Picks - newser.com
Will Heron Therapeutics Inc. stock attract more institutional investorsInsider Selling & Reliable Breakout Forecasts - newser.com
Tools to monitor Heron Therapeutics Inc. recovery probabilityWeekly Gains Report & Risk Controlled Swing Alerts - newser.com
Should you wait for a breakout in Heron Therapeutics Inc.Portfolio Return Report & Entry and Exit Point Strategies - newser.com
Developing predictive dashboards with Heron Therapeutics Inc. data2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com
Is Heron Therapeutics Inc. (AXD2) stock inflation resilient2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
What MACD and RSI say about Heron Therapeutics Inc.Weekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Will Heron Therapeutics Inc. stock outperform Nasdaq indexTrade Entry Report & Fast Moving Trade Plans - newser.com
Heron Therapeutics Inc (HRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):